Treatment options for restrictive lung disease

Treating a patient with respiratory failure associated with a restrictive lung disease, mainly chest wall disorder, can help alleviate some of the symptoms of poor respiration, including:

  • dyspnoea on exertion1
  • peripheral edema1
  • orthopnoea1
  • morning headaches1
  • fatigue1
  • poor sleep quality1
  • loss of appetite.

Indications for NIV for the treatment of respiratory failure include symptoms or signs of corpulmonale, and one of the following:

  • Daytime arterial PaCO2 ≥ 45 mmHg
  • Nocturnal SaO2 < 88% for five consecutive minutes
  • Progressive neuromuscular disease (NMD) with PImax < 60 cmH2O or FVC < 50% of predicted value

Noninvasive ventilation (NIV) is an effective treatment option for hypercapnic respiratory failure in patients with a chest wall disorder.1

Reference

  • 01

    Shneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J. 2002; 20:480-487

More about restrictive lung disease